Jellatech Expands Bioidentical Human Collagen Production at New 9,000-Square-Foot Facility

Bluestein Associates 11/6/24 Bluestein Associates 11/6/24

Jellatech Expands Bioidentical Human Collagen Production at New 9,000-Square-Foot Facility

Read More

Jellatech Raises $3.5M to Scale its Cell-Based Collagen Platform

Bluestein Associates 8/22/23 Bluestein Associates 8/22/23

Jellatech Raises $3.5M to Scale its Cell-Based Collagen Platform

Read More

Jellatech Announces Development of Cell-Based Human Collagen From Their Own Proprietary Cell Line

Bluestein Associates 3/10/23 Bluestein Associates 3/10/23

Jellatech Announces Development of Cell-Based Human Collagen From Their Own Proprietary Cell Line

Read More

Jellatech Reveals its First Animal-Free, Cell-Based Collagen

Bluestein Associates 6/27/22 Bluestein Associates 6/27/22

Jellatech Reveals its First Animal-Free, Cell-Based Collagen

Read More

Stephanie Michelsen, Founder & CEO of Jellatech, makes Forbes’ 30-Under-30

Bluestein Associates 11/30/21 Bluestein Associates 11/30/21

Stephanie Michelsen, Founder & CEO of Jellatech, makes Forbes’ 30-Under-30

Read More

Talking Cell-Based Collagen with Jellatech’s Stephanie Michelsen

Bluestein Associates 10/4/21 Bluestein Associates 10/4/21

Talking Cell-Based Collagen with Jellatech’s Stephanie Michelsen

Read More

Jellatech Announces $2M Pre-seed Round

Bluestein Associates 4/19/21 Bluestein Associates 4/19/21

Jellatech Announces $2M Pre-seed Round

Foxtrot Market ramps up private label with two senior-level hires.

Read More